Tenet Healthcare Appoints Vineeta Agarwala to Board of Directors
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
“We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace.”
Dr. Agarwala is a General Partner at Andreessen Horowitz (a16z), where she leads investments for the firm’s Bio + Health fund across biotech and digital health. She focuses on partnering with companies leveraging unique technologies and datasets to advance drug development, personalized medicine, and novel approaches to patient care delivery.
Dr. Agarwala holds M.D. and Ph.D. degrees from Harvard Medical School / MIT, and a B.S. degree in biophysics from Stanford University. Her experience includes research at the prestigious Broad Institute in computational biology and human genetics. She completed her clinical residency at Stanford, and is board certified in internal medicine.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20231212460938/en/
Investor Contact
Will McDowell
469-893-2387
William.McDowell@tenethealth.com
Media Contact
Robert Dyer
469-893-2640
mediarelations@tenethealth.com
Source: Tenet Healthcare Corporation